Researchers leveraged structural insights to engineer a single-chain human IL-2/F5111 antibody fusion protein, termed F5111 immunocytokine, which potently and selectively activated and expanded Tregs.
[Cell Reports]
Engineered Human Cytokine/Antibody Fusion Proteins Expand Regulatory T Cells and Confer Autoimmune Disease Protection
